What is the best antibiotic for a 71-year-old man with a positive urinalysis and urine culture growing >100,000 CFU of lactose‑fermenting gram‑negative rods, no drug allergies, and normal renal function (glomerular filtration rate > 90 mL/min, serum creatinine 0.8 mg/dL)?

Antibiotic Selection for UTI in a 71-Year-Old Man

For this 71-year-old gentleman with a positive urine culture growing >100,000 CFU of lactose-fermenting gram-negative rods (presumed E. coli) and normal renal function, trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days is the recommended first-line empirical treatment. 1

Rationale for Treatment Selection

Classification as Complicated UTI

• UTIs in men are automatically classified as complicated UTIs because male gender is a recognized complicating factor, even in the absence of anatomic abnormalities or other risk factors 1
• This classification necessitates a longer treatment duration (7 days minimum) compared to uncomplicated cystitis in women (3-5 days) 1
• The 7-day duration accounts for the possibility of occult prostatitis, which cannot be definitively excluded in male patients 1

First-Line Antibiotic Choice

Trimethoprim-sulfamethoxazole (TMP-SMX) is specifically recommended for men with UTI according to the 2024 European Association of Urology guidelines 1:

• Dosing: 160/800 mg twice daily for 7 days 1
• This agent provides excellent coverage against E. coli and other common gram-negative uropathogens
• His normal renal function (GFR >90, creatinine 0.8) allows safe use without dose adjustment

Alternative Options

Fluoroquinolones can also be prescribed as an alternative first-line agent for men with UTI 1:

• Ciprofloxacin: 500-750 mg twice daily for 7 days 1
• Levofloxacin: 750 mg once daily for 5-7 days 1
• However, fluoroquinolones should only be used if local E. coli resistance rates are <10% 1
• Growing resistance patterns (up to 39.9% in some populations) and ecological concerns limit their routine use 2

Important Clinical Considerations

Verify local resistance patterns before finalizing treatment 1:

• If local TMP-SMX resistance exceeds 20%, consider alternative agents 1
• Lactose-fermenting gram-negative rods strongly suggest E. coli, which typically shows good susceptibility to TMP-SMX, fosfomycin, and nitrofurantoin 2
• E. coli demonstrates 95.5% susceptibility to fosfomycin and 85.5% to nitrofurantoin in recent studies 2

Avoid certain agents in this clinical scenario 1:

• Nitrofurantoin, fosfomycin, and pivmecillinam should be avoided for potential upper tract involvement, as there is insufficient efficacy data for pyelonephritis 1
• These agents are appropriate only for uncomplicated cystitis in women 1

When to Escalate Therapy

Consider parenteral therapy if the patient develops systemic symptoms 1:

• Fever >38°C, chills, flank pain, or hemodynamic instability warrant IV antibiotics 1
• Ceftriaxone 1-2 g once daily is the recommended empirical IV choice for normal hosts 1
• Fluoroquinolones (ciprofloxacin 400 mg IV twice daily or levofloxacin 750 mg IV daily) are alternatives 1

Tailor therapy based on culture results 1:

• Once susceptibility data are available, narrow or adjust antibiotics accordingly
• If the organism proves resistant to initial empirical therapy, switch to an appropriate agent for a full 7-day course 1
• Extended-spectrum beta-lactamase (ESBL) producers (4.2% of E. coli) may require carbapenems or other specialized agents 3

Common Pitfalls to Avoid

• Do not treat for only 3 days: This duration is appropriate only for uncomplicated cystitis in women, not for men 1
• Do not use nitrofurantoin as first-line in men: While effective for lower tract infections, the 7-day duration needed in men and potential for upper tract involvement make it suboptimal 1
• Do not assume all gram-negative rods are equally susceptible: Verify the specific organism and susceptibility once culture results finalize 1
• Do not overlook the need for follow-up: If symptoms persist beyond 72 hours or recur within 2 weeks, obtain repeat culture and consider imaging to exclude complications 1